Health-related quality of life and colorectal cancer-specific symptoms in patients with chemotherapy-refractory metastatic disease treated with panitumumab

PURPOSE: Panitumumab monotherapy is approved for chemotherapy-refractory wild-type KRAS metastatic colorectal cancer (mCRC). Patient-reported outcomes—although important in the palliative setting—have not been reported in this patient population. METHODS: In a phase 3 trial (n = 463), patients with...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Odom, Dawn, Barber, Beth, Bennett, Lee, Peeters, Marc, Zhao, Zhongyun, Kaye, James, Wolf, Michael, Wiezorek, Jeffrey
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Springer-Verlag 2010
Onderwerpen:
Original Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3024508/
https://ncbi.nlm.nih.gov/pubmed/21190026
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00384-010-1112-5
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items